Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Intern Med ; 261(1): 91-100, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17222172

ABSTRACT

BACKGROUND: Nontyphoid Salmonella (NTS) isolates lead to not only self-limited, acute gastrointestinal infections, but also bacteraemia with or without extraintestinal focal infections (EFIs). The risk factors associated with EFIs in adults with NTS bacteraemia were not clearly elucidated. METHODS: In a medical center in southern Taiwan, patients aged > or = 18 years with NTS bacteraemia between January 1999 and June 2005 were included for analysis. RESULTS: Of 129 patients, 51 (39.5%) were complicated with EFIs. The most common EFI was mycotic aneurysm, followed by pleuropulmonary infections and spinal osteomyelitis. Compared to patients with primary bacteraemia, those with EFIs had higher leucocyte counts (P = 0.004) and higher serum levels of C-reactive protein (P < 0.0001). The development of EFIs was associated with a higher mortality, more severe septic manifestations, longer hospital stays and duration of antimicrobial therapy. Univariate analysis revealed that diabetes mellitus (P = 0.02), hypertension (P = 0.02) and chronic lung disease (P = 0.006) were significantly associated with EFIs. However, patients with malignancy (P = 0.01) and immunosuppressive therapy (P = 0.03) were less likely to develop EFIs. On the basis of multivariate analysis, an independent factor for the occurrence of EFIs was age [adjusted odds ratio (aOR) 1.05; 95% confidence interval (CI) 1.02-1.07; P < 0.0001], whilst malignancy was negatively associated with EFIs (aOR 0.16; 95% CI 0.14-0.78; P = 0.01). CONCLUSION: Amongst patients with NTS bacteraemia, EFIs often occurred in the aged, and were associated with a higher mortality and morbidity. Recognition of specific host factors is essential for identification of EFIs which often demand early surgical interventions and prolonged antimicrobial therapy.


Subject(s)
Focal Infection/diagnosis , Salmonella Infections/diagnosis , Adult , Aged , Aneurysm, Infected/diagnosis , Aneurysm, Infected/drug therapy , Aneurysm, Infected/mortality , Anti-Bacterial Agents/therapeutic use , Bacteremia/diagnosis , Bacteremia/drug therapy , Bacteremia/mortality , Drug Resistance, Bacterial , Epidemiologic Methods , Female , Fever/microbiology , Focal Infection/drug therapy , Focal Infection/mortality , Humans , Lung Diseases/diagnosis , Lung Diseases/drug therapy , Lung Diseases/mortality , Male , Middle Aged , Osteomyelitis/diagnosis , Osteomyelitis/drug therapy , Osteomyelitis/mortality , Salmonella Infections/drug therapy , Salmonella Infections/mortality , Shock, Septic/diagnosis , Taiwan/epidemiology , Treatment Outcome
2.
Kansenshogaku Zasshi ; 75(11): 981-8, 2001 Nov.
Article in Japanese | MEDLINE | ID: mdl-11766382

ABSTRACT

We report an 8-year-old boy with acute focal bacterial nephritis (AFBN). At the age of 3 months, he had a history of urinary tract infection and vesicoureteral reflux. He was admitted to our hospital because of high fever and costovertebral angle pain. Although acute pyelonephritis was suspected, neither pyuria nor cultures of blood and urine were positive. An initial ultrasonogram (US) of his kidneys was normal except for bilateral hydronephrosis. Two days later, however, a computed tomography (CT) revealed a poorly enhanced mass in the upper pole of the right kidney. Similar findings were also observed by US. Under the diagnosis of AFBN, he received antibiotics for 3 weeks. Voiding cystourethrogram showed both-sided vesicoureteral reflux and he underwent an operation. At present the mass of the kidney still remains, albeit its size tends to decrease. We suggest that an early examination of US or enhanced CT is necessary in cases with fever of unknown origin, considering the possibility of AFBN even if neither pyuria nor cultures of urine are positive.


Subject(s)
Bacterial Infections/diagnosis , Focal Infection/diagnosis , Nephritis/diagnosis , Acute Disease , Bacterial Infections/diagnostic imaging , Bacterial Infections/microbiology , Child , Focal Infection/diagnostic imaging , Focal Infection/mortality , Humans , Male , Nephritis/diagnostic imaging , Nephritis/microbiology , Tomography, X-Ray Computed , Ultrasonography , Urinary Tract Infections/complications , Vesico-Ureteral Reflux/complications
3.
Infection ; 20(4): 207-12, 1992.
Article in English | MEDLINE | ID: mdl-1521886

ABSTRACT

Severe focal viral encephalitis is most commonly caused by herpes simplex virus (HSV), but other viruses may act as etiologic agents as well. Acyclovir (ACV) is the standard therapy for HSV encephalitis, but the mortality of 28% and defect healing rate of about 35% are still unsatisfactory. Furthermore, ACV has virtually no effect on other pathogens of viral encephalitis, except for varicella-zoster virus (VZV). It is well known that beta-interferon (beta-IFN) has a broad antiviral spectrum, and it has been demonstrated in vitro that beta-IFN in combination with acyclovir has synergistic inhibitory effects on HSV. To investigate if the combination of ACV with and without beta-IFN might also be of significance for the treatment of severe viral encephalitis, we performed a retrospective study. A case record form was sent to all 278 West German children's hospitals. The response rate was 78%. A total of 301 patients were reported, of whom 214 received specific antiviral therapy with either ACV alone (n = 179) or ACV plus beta-IFN (n = 35). No overall differences between ACV monotherapy and the combination therapy were observed. However, in a subgroup of 41 patients (ACV n = 30, ACV plus beta-IFN n = 11) who had low-density areas of the temporal lobes on cranial computed tomography scans, compatible with severe focal encephalitis, sequelae due to defect formation and mortality were significantly (p = 0.014) reduced in patients who had received combination therapy.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Acyclovir/therapeutic use , Encephalitis/drug therapy , Focal Infection/drug therapy , Herpes Simplex/drug therapy , Interferon-beta/therapeutic use , Acyclovir/administration & dosage , Acyclovir/pharmacology , Child , Child, Preschool , Combined Modality Therapy , Drug Synergism , Encephalitis/diagnostic imaging , Encephalitis/mortality , Female , Focal Infection/diagnostic imaging , Focal Infection/mortality , Germany/epidemiology , Herpes Simplex/diagnostic imaging , Herpes Simplex/mortality , Hospitals, Pediatric , Humans , Infant , Interferon-beta/administration & dosage , Interferon-beta/pharmacology , Male , Retrospective Studies , Tomography, X-Ray Computed , Treatment Outcome
4.
Chirurg ; 63(3): 174-80, 1992 Mar.
Article in German | MEDLINE | ID: mdl-1559398

ABSTRACT

The therapeutical concept of programmed relaparotomy was performed in 184 patients with diffuse peritonitis from 4/1984 to 4/1991. Clinical results were prospectively documented and a total of 46 variables (e.g. risk factors, clinical parameters, laboratory tests, microbiological screenings, score systems) both univariate and multivariate were tested for prognostic significance. Total lethality rate was 26% (48/184 patients). If complete eradication of the source of infection was surgically achieved (150 patients/82%) lethality rate was only 9%. In contrast, lethality rate was 100% in patients with unsuccessful surgical focus eradication. Eradication of the source of infection during the first operation (104 patients/56%) resulted in a lethality rate of 6%, compared to 17% for patients who needed two or even more operations (46 patients/25%). Eradication of the source of infection during the first laparotomy ("focus eradication on time") was the most important prognostic parameters. Of further prognostic significance but with declining importance where serum-creatinine at the beginning of the treatment, patient's age (greater than less than 70 years) and preexistent hepatic disease.


Subject(s)
Laparotomy , Peritonitis/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Female , Focal Infection/epidemiology , Focal Infection/mortality , Focal Infection/surgery , Humans , Laparotomy/adverse effects , Laparotomy/statistics & numerical data , Male , Middle Aged , Multiple Organ Failure/epidemiology , Multivariate Analysis , Peritonitis/epidemiology , Peritonitis/mortality , Postoperative Complications/epidemiology , Prognosis , Regression Analysis , Reoperation/adverse effects , Reoperation/statistics & numerical data , Risk Factors , Severity of Illness Index , Time Factors
5.
Article in Russian | MEDLINE | ID: mdl-1441815

ABSTRACT

The influence of dimephosphone at concentrations of 0.001 M-0.75 M on the chemiluminescence of tissues at the focus of purulent infection in the ear of a guinea pig, on the survival rate of the experimental animals injected with the lethal dose of Staphylococcus aureus, as well as on the spontaneous and stimulated chemiluminescence of blood neutrophils in patients with wound infection, was studied. The study showed that different concentrations of dimephosphone oppositely influenced the intensity of the chemiluminescence of neutrophil suspensions and tissues at the focus of infection: low concentrations were found to produce stimulating action and high concentrations, suppressive action. At the highest concentration used in this study (0.75 M) dimephosphone prevented the death of the animals receiving lethal doses of S. aureus.


Subject(s)
Adjuvants, Immunologic/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Focal Infection/drug therapy , Luminescent Measurements , Neutrophils/drug effects , Organophosphorus Compounds/therapeutic use , Staphylococcal Skin Infections/drug therapy , Animals , Cells, Cultured/drug effects , Cells, Cultured/metabolism , Chi-Square Distribution , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Focal Infection/metabolism , Focal Infection/mortality , Guinea Pigs , Humans , Male , Neutrophils/metabolism , Staphylococcal Skin Infections/metabolism , Staphylococcal Skin Infections/mortality , Wound Infection/drug therapy , Wound Infection/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...